Cargando…
Transiently expressed CRISPR/Cas9 induces wild-type dystrophin in vitro in DMD patient myoblasts carrying duplications
Among the mutations arising in the DMD gene and causing Duchenne Muscular Dystrophy (DMD), 10–15% are multi-exon duplications. There are no current therapeutic approaches with the ability to excise large multi-exon duplications, leaving this patient cohort without mutation-specific treatment. Using...
Autores principales: | Pini, Veronica, Mariot, Virginie, Dumonceaux, Julie, Counsell, John, O’Neill, Helen C., Farmer, Sarah, Conti, Francesco, Muntoni, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904532/ https://www.ncbi.nlm.nih.gov/pubmed/35260651 http://dx.doi.org/10.1038/s41598-022-07671-w |
Ejemplares similares
-
Necroptosis mediates myofibre death in dystrophin-deficient mice
por: Morgan, Jennifer E., et al.
Publicado: (2018) -
Publisher Correction: Necroptosis mediates myofibre death in dystrophin-deficient mice
por: Morgan, Jennifer E., et al.
Publicado: (2018) -
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System
por: Lattanzi, Annalisa, et al.
Publicado: (2017) -
Characterization of brain dystrophins absence and impact in dystrophin-deficient Dmd(mdx) rat model
por: Caudal, Dorian, et al.
Publicado: (2020) -
Generation of two genomic-integration-free DMD iPSC lines with mutations affecting all dystrophin isoforms and potentially amenable to exon-skipping
por: Ferrari, Giulia, et al.
Publicado: (2020)